Belite Bio (BLTE) Other Accumulated Expenses (2021 - 2025)

Belite Bio's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $599000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses rose 4507.69% year-over-year to $599000.0; the TTM figure through Dec 2025 stood at $599000.0 (up 4507.69% YoY), while the FY2025 annual figure was $599000.0, up 4507.69% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $599000.0, up from $13000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $599000.0 in Q4 2025, with the low at $13000.0 in Q4 2024.
• The 5-year median for Other Accumulated Expenses is $95000.0 (2021), against an average of $177800.0.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses slumped 87.96% in 2024, then surged 4507.69% in 2025.
• Belite Bio's Other Accumulated Expenses stood at $95000.0 in 2021, then retreated by 22.11% to $74000.0 in 2022, then soared by 45.95% to $108000.0 in 2023, then plunged by 87.96% to $13000.0 in 2024, then soared by 4507.69% to $599000.0 in 2025.
• Business Quant data shows BLTE's Other Accumulated Expenses at $599000.0 in Q4 2025, $13000.0 in Q4 2024, and $108000.0 in Q4 2023.